Tag: Multiple Sclerosis
The first pill for MS sufferers is set to be approved for use on the NHS.The National Institute for Curbing Expendtiture (NICE) has overturned previous draft guidance on the drug Fingolimod after the price was discounted and has now ruled that a proportion of people with multiple sclerosis should be treated with it. MS is […]
Posted: March 19th, 2012 under Doctors, Health, Health Professionals, Multiple Sclerosis, NHS Cash Shortages, NICE, Preventable Crisis, Quangoes, Risk of Drugs, Uncategorized.
Tags: Doctors, Health Professionals, Multiple Sclerosis, NICE blight, preventable crisis, Quangos
The results of a Phase III trial have shown the ability of GW Pharmaceuticals’ cannabinoid based medicine Sativex to reduce severe spasticity associated with Multiple Sclerosis. According to the data, published in the European Journal of Neurology, about half of MS patients who had failed to respond to standard therapy experienced an improvement in spasticity […]
Posted: March 16th, 2011 under Doctors, Drugs, Multiple Sclerosis, postcode lottery, red tape, Risk of Drugs, Uncategorized.
Tags: cancer drugs, Cannabis, Doctors, drugs classification, MS, Multiple Sclerosis, postcode lottery, Risk of Drugs
Concerns over the link between rising skin cancer rates and exposure to sunshine may have led to overly precautionary advice being given to the public about staying out of the sun at midday, according to a confidential “position statement” by leading health organisations. The current advice to the public from the leading research charity on […]
The first licensed medical drug containing whole cannabis plant extracts has been launched to treat symptoms of multiple sclerosis (MS). Sativex will be made widely available after it was approved by the medicines regulator last week. Taken as a mouth spray, it is used to help alleviate symptoms of spasticity – involuntary muscle stiffness and […]